Robitzki A., Schroder HC, Ugarkovic D. et al. cDNA structure and expression of calpactin, a peptide involved in Ca2+ -dependent cell aggregation in sponges. Biochem J1990; 271: 415-20.
4.
Schlaepfer DD , Fisher DA, Brandt ME et al. Expression of annexins as a function of cellular growth state. Two novel annexins from Drosophila melanogaster . J Biol Chem1990; 267: 9529-39.
5.
Johnston PA, Perin MS, Reynolds GA, Wasserman SA, Südhof TCTwo novel annexins from Drosophila melanogaster. Cloning, characterization and differential expression in development. J Biol Chem1990; 265: 11382-8.
6.
Huang KS, Wallner BP, Mattaliano RJ et al. Two human 35 kD inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase . Cell1986; 46: 191-9.
7.
Wallner BP, Mattaliano RJ, Hession C. et al. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential antiinflammatory activity. Nature (London)1986; 320: 77-81.
8.
Pepinsky RB, Tizard R., Mattaliano RJ et al. Five distinct calcium and phospholipid binding proteins share homology with lipocortin I. J Biol Chem1988 ; 263: 10799-811.
9.
Funakoshi T. , Hendrickson LE, McMullen BA, Fujikawa K.Primary structure of human placental anticoagulant protein. Biochemistry1987; 26: 8087-92.
10.
Crompton MR , Owens RJ, Totty NF, Moss SE, Waterfield MD, Crumpton MJPrimary structure of the human, membrane-associated Ca2+-binding protein p68, a novel member of a protein family. EMBO J1988; 7: 21-7.
11.
Bums AL, Magendzo K., Shirvan A. et al. Calcium channel activity of purified human synexin and structure of the human synexin gene. Proc Natl Acad Sci USA1989; 86: 3798-802.
12.
Hauptmann R. , Maurer-Fogy I., Krystek E. et al. Vascular anticoagulant beta: a novel human Ca2+/phospholipid binding protein that inhibits coagulation and phospholipase A2 activity. Its molecular cloning, expression and comparison with VAC-alpha . Eur J Biochem1989; 185: 63-71.
13.
Towle CA, Treadwell BVIdentification of a novel mammalian annexin. cDNA cloning, sequence analysis, and ubiquitous expression of the annexin XI gene. J Biol Chem1992; 267: 5416-23.
14.
Wice BM, Gordon JIA strategy for isolation of cDNAs encoding proteins affecting human intestinal epithelial cell growth and differentiation: characterization of a novel gut-specific N-myristoylated annexin. J Cell Biol1992; 116: 405-22.
15.
Crompton MR , Moss SE, Crumpton MJDiversity in the lipocortin/ calpactin family . Cell1988; 55: 1-3.
16.
Huber R., Schneider M., Mayr I., Römisch J., Paques E-P.The calcium binding sites in human annexin V by crystal structure analysis at 2.0 Å resolution. Implications for membrane binding and calcium channel activity. Febs Lett1990; 275: 15-21.
17.
Weng X., Luecke H., Song IS et al. Crystal structure of human annexin I at 2.5 Å resolution. Protein Sci1993; 2: 448-58.
Raynal P., Pollard HBAnnexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta1994; 1197: 63-93.
22.
Wang W., Creutz CERole of the amino-terminal domain in regulating interactions of annexin-I with membranes: effects of amino-terminal truncation and mutagenesis of the phosphorylation sites. Biochemistry1994; 33: 275-82.
23.
Wang W., Cretuz CERegulation of the chromaffin granule aggregating activity of annexin I by phosphorylation. Biochemistry1992; 31: 9934-9.
24.
Johnstone SA , Hubaishy I., Waisman DMPhosphorylation of annexin II tetramer by protein kinase C inhibits aggregation of lipid vesicles by the protein. J Biol Chem1992; 267: 259.76-81.
25.
Mizutani A. , Tokumitsu H., Kobayashi R., Hidaka H.Phosphorylation of annexin XI (CAP-50) in SR-3Y1 cells. J Biol Chem1993; 268: 15517-22.
26.
Blackwood RA , Ernst JDCharacterization of Ca2+-dependent phospholipid binding, vesicle aggregation. and membrane fusion by annexins . Biochem J1990; 266: 195-200.
27.
Andree HA, Willems GM, Hauptmann R. et al. Aggregation of phospholipid vesicles by a chimeric protein with the N-terminus of annexin I and the core of annexin V. Biochemistry1993; 32: 4634-40.
28.
Hoekstra D. , Buistarkema R., Klappe K., Reutelingsperger Cpm.Interaction of annexins with membranes: the N-terminus as a governing parameter as revealed with a chimeric annexin. Biochemistry1993 ; 32: 14194-202.
29.
Ernst JD, Hoye E., Blackwood RA, Mok TLIdentification of a domain that mediates vesicle aggregation reveals functional diversity of annexin repeats. J Biol Chem1991; 266: 6670-3.
30.
Huber R., Römisch J., Paques EPThe crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. Embo J1990; 9: 3867-74.
31.
Driessen HP , Newman RH, Freemont PS, Crumpton MJA model of the structure of human annexin VI bound to lipid monolayers. FEBS Lett1992 ; 306: 75-9.
32.
Schlaepfer DD, Mehlman T., Burgess WH, Haigler HTStructural and functional characterization of endonexin II, a calcium- and phospholipid-binding protein. Proc Natl Acad Sci USA1987; 84: 6078-82.
33.
Meers P., Mealy T.Relationship between annexin V tryptophan exposure, calcium and phospholipid binding. Biochemistry1993; 32: 5411-18.
34.
Sopkova J., Gallay J., Vincent M., Pancoska P., Lewitbentley A.The dynamic behavior of annexin V as a function of calcium ion binding: a circular dichroism, UV absorption and steady-state and time-resolved fluorescence study. Biochemistry1994; 33: 4490-9.
35.
Mosser G., Ravanat C., Freyssinet JM, Brisson A.Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis . J Mol Biol1991; 217: 241-5.
36.
Andree HA, Stuart MC, Hermens WT et al. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem1992; 267: 17907-12.
37.
Ravanat C., Torbet J., Freyssinet JMA neutron solution scattering study of the structure of annexin-V and its binding to lipid vesicles. J Mol Biol1992 ; 226: 1271-8.
38.
Voges D., Berendes R., Burger A., Demange P., Baumeister W., Huber R.Three-dimensional structure of membrane-bound annexin V: a correlative electron microscopy X-ray crystallography study. J Mol Biol1994; 238: 199-213.
39.
Pfäfle M., Borchert M., Deutzmann R. et al. Anchorin CII, a collagen-binding chondrocyte surface protein of the calpactin family. Prog Clin Biol Res1990; 349: 147-57.
40.
Wirl G., Schwartz ARCollagen-binding proteins of mammary epithelial cells are related to Ca2+- and phospholipid-binding annexins. J Cell Physiol1990; 144: 511-22.
41.
Genge BR, Wu LN, Wuthier REIdentification of phospholipid-dependent calcium-binding proteins as constitutents of matrix vesicles. J Biol Chem1989; 264: 10917-21.
42.
Christmas P. , Callaway J., Fallon J., Jones J., Haigler HTSelective secretion of annexin I. a protein without a signal sequence, by the human prostate gland . J Biol Chem1991; 266: 2499-507.
43.
Solito E., Raugei G., Melli M., Parente L.Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated u-937 cells. FEBS Lett1991; 291: 238-44.
44.
Violette SM , King I., Browning JL, Pepinsky RB, Wallner BP, Sartorelli ACRole of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J Cell Physiol1990; 142: 70-7.
45.
Croxtall JD , Flower RJLipocortin I mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. proc Natl Acad Sci USA1992; 89: 3571-5.
46.
Hertogs K., Leenders Wpj, Depla E. et al. Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein . Virology1993; 197: 549-57.
47.
Flaherty MJ , West S., Heimark RL, Fujikawa K., Tait JFPlacental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system. J Lab Clin Med1990; 115: 174-81.
48.
Uemura K., Inagaki H., Wada Y. et al. Identification of immuno-reactive lipocortin 1-like molecules in serum and plasma by an enzyme immunoassay for lipocortin 1. Biochim Biophys Acta1992; 1119: 250-5.
49.
Thiagarajan P., Tait JFBinding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem1990; 265: 17420-3.
50.
Thiagarajan P., Tait JFCollagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem1991; 266: 24302-7.
51.
Dachary PJ, Freyssinet JM, Pasquet JM, Carron JC, Nurden ATAnnexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a. role for free sulfhydryl groups . Blood1993; 81: 2554-65.
52.
Van Heerde WL, Poort S., van't Veer C., Reutelingsperger Cpm, de Groot PhG.Binding of recombinant annexin V to endothelial cells. Implications for the endothelial cell-mediated thrombin formation. Biochem J1994 (in press).
53.
Van Heerde WL , Sakariassen KS, Hemker HC, Sixma JJ, Reutelingsperger CP, de Groot PG.Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions. Arterioscler Thrombos1994; 14: 824-30.
54.
Ravanat C., Archipoff G., Beretz A., Freund G., Cazenave JP, Freyssinet JMUse of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem J1992; 282: 7-13.
55.
Römisch J., Seiffge D., Reiner G., Paques EP, Heimburger N.In vivo antithrombotic potency of placenta protein 4 (annexin V). Thromb Res1991; 61: 93-104.
56.
Van Rmj, Merk H., Muller TH, Buchanan MR, Eisert WGThe effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits. Thromb Haemost1993 ; 69: 227-30.
57.
Rand JH, Wu XX, Nemerson Y., Lockwood J.Deficiency of annexin V (placental anticoagulant protein-I) on the surfaces of placental villi of women with antiphospholipid antibodies and recurrent abortion. Thromb Haemost1993; 69: 953 (abstract).